Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sun Pharma Advanced Research Company has informed that it enclosed details of loss of share certificates/request for issue of duplicate share certificate reported by shareholder of the Company, Krishna Ramchandra Thakkar (Folio No: 014143) received from its Registrar and Transfer Agent, Link Intime India on January 28, 2022. More details are attached.
The above information is a part of company’s filings submitted to BSE.
